Colleen represents emerging high-growth companies throughout their life cycle, with a focus on all aspects of emerging company development – including corporate formation, venture capital financings, corporate spinouts and restructurings, mergers and acquisitions, and capital markets transactions. She also has experience representing venture capital and angel investors in their investment transactions. Since 2021, Colleen has handled VC financings with an aggregate deal value of more than $2.5 billion. Colleen is counsel to companies and their investors in a broad range of high-growth industries, including the life sciences, digital health, software, technology and consumer sectors.
